ArticleBiomedical optics express2025
Ultra-low limit of detection of a carcinoembryonic antigen fiber sensor based on microfiber.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fiber optic sensors have been widely applied to address issues such as cardiovascular diseases, pathogen detection, and cancer biomarker detection. In this work, an ultra-low limit of detection, high-specificity, and label-free optical fiber biosensor for the detection of carcinoembryonic antigen (CEA) was proposed and experimentally demonstrated. A microfiber interferometer with refractive index sensitivity of up to 1915.955 nm/RIU was employed as the sensor head. The sensitivity of the sensor was further enhanced by the incorporation of molybdenum disulfide (MoS
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.